Mortality following bone metastasis and skeletal-related events among women with breast cancer

A population-based analysis of U.S. Medicare beneficiaries, 1999-2006

Nalini Sathiakumar, Elizabeth Delzell, Michael A. Morrisey, Carla Falkson, Mellissa Yong, Victoria Chia, Justin Blackburn, Tarun Arora, Ilene Brill, Meredith L. Kilgore

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The aim of the study is to quantify the impact of bone metastasis and skeletal-related events (SREs) on mortality in older breast cancer patients. Using the linked Surveillance, Epidemiology and End Results-Medicare database, we identified women aged 65 years or older diagnosed with breast cancer between July 1, 1999 and December 31, 2005 and followed them to determine deaths occurring through December 31, 2006. We classified patients as having possible bone metastasis and SREs using discharge diagnoses from inpatient claims and diagnoses paired with procedure codes from outpatient claims. We used Cox regression to estimate mortality hazards ratios (HR) among women with bone metastasis with or without SRE, compared with women without bone metastasis. Among 98,260 women with breast cancer (median follow-up, 3.3 years), 7,189 (7.3%) had bone metastasis either at breast cancer diagnosis (1.5%) or during follow-up (5.8%). SREs occurred in 3,319 (46%) of women with bone metastasis. HRs for risk of death were 4.9 (95% CI 4.7-5.1) and 6.2 (95% CI 5.9-6.5), respectively, for women with bone metastasis but no SRE and for women with bone metastasis plus SRE, compared with women without bone metastasis. In analyses restricted to women with bone metastasis, the adjusted HR was 1.5 (95% CI 1.4-1.6) for women with bone metastasis plus SRE, compared with women with bone metastasis but without SRE. Having a bone metastasis, as indicated by Medicare claims, was associated strongly with mortality among women with breast cancer. This association was stronger for bone metastasis complicated by SRE than for bone metastasis without SRE.

Original languageEnglish (US)
Pages (from-to)231-238
Number of pages8
JournalBreast Cancer Research and Treatment
Volume131
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Medicare
Breast Neoplasms
Neoplasm Metastasis
Bone and Bones
Mortality
Population
Inpatients
Epidemiology
Outpatients

Keywords

  • Bone metastasis
  • Breast cancer
  • Medicare beneficiaries
  • Skeletal-related events

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Mortality following bone metastasis and skeletal-related events among women with breast cancer : A population-based analysis of U.S. Medicare beneficiaries, 1999-2006. / Sathiakumar, Nalini; Delzell, Elizabeth; Morrisey, Michael A.; Falkson, Carla; Yong, Mellissa; Chia, Victoria; Blackburn, Justin; Arora, Tarun; Brill, Ilene; Kilgore, Meredith L.

In: Breast Cancer Research and Treatment, Vol. 131, No. 1, 01.01.2012, p. 231-238.

Research output: Contribution to journalArticle

Sathiakumar, Nalini ; Delzell, Elizabeth ; Morrisey, Michael A. ; Falkson, Carla ; Yong, Mellissa ; Chia, Victoria ; Blackburn, Justin ; Arora, Tarun ; Brill, Ilene ; Kilgore, Meredith L. / Mortality following bone metastasis and skeletal-related events among women with breast cancer : A population-based analysis of U.S. Medicare beneficiaries, 1999-2006. In: Breast Cancer Research and Treatment. 2012 ; Vol. 131, No. 1. pp. 231-238.
@article{83b525e6a4f5467ba14e70ccfc85e91d,
title = "Mortality following bone metastasis and skeletal-related events among women with breast cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006",
abstract = "The aim of the study is to quantify the impact of bone metastasis and skeletal-related events (SREs) on mortality in older breast cancer patients. Using the linked Surveillance, Epidemiology and End Results-Medicare database, we identified women aged 65 years or older diagnosed with breast cancer between July 1, 1999 and December 31, 2005 and followed them to determine deaths occurring through December 31, 2006. We classified patients as having possible bone metastasis and SREs using discharge diagnoses from inpatient claims and diagnoses paired with procedure codes from outpatient claims. We used Cox regression to estimate mortality hazards ratios (HR) among women with bone metastasis with or without SRE, compared with women without bone metastasis. Among 98,260 women with breast cancer (median follow-up, 3.3 years), 7,189 (7.3{\%}) had bone metastasis either at breast cancer diagnosis (1.5{\%}) or during follow-up (5.8{\%}). SREs occurred in 3,319 (46{\%}) of women with bone metastasis. HRs for risk of death were 4.9 (95{\%} CI 4.7-5.1) and 6.2 (95{\%} CI 5.9-6.5), respectively, for women with bone metastasis but no SRE and for women with bone metastasis plus SRE, compared with women without bone metastasis. In analyses restricted to women with bone metastasis, the adjusted HR was 1.5 (95{\%} CI 1.4-1.6) for women with bone metastasis plus SRE, compared with women with bone metastasis but without SRE. Having a bone metastasis, as indicated by Medicare claims, was associated strongly with mortality among women with breast cancer. This association was stronger for bone metastasis complicated by SRE than for bone metastasis without SRE.",
keywords = "Bone metastasis, Breast cancer, Medicare beneficiaries, Skeletal-related events",
author = "Nalini Sathiakumar and Elizabeth Delzell and Morrisey, {Michael A.} and Carla Falkson and Mellissa Yong and Victoria Chia and Justin Blackburn and Tarun Arora and Ilene Brill and Kilgore, {Meredith L.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/s10549-011-1721-x",
language = "English (US)",
volume = "131",
pages = "231--238",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Mortality following bone metastasis and skeletal-related events among women with breast cancer

T2 - A population-based analysis of U.S. Medicare beneficiaries, 1999-2006

AU - Sathiakumar, Nalini

AU - Delzell, Elizabeth

AU - Morrisey, Michael A.

AU - Falkson, Carla

AU - Yong, Mellissa

AU - Chia, Victoria

AU - Blackburn, Justin

AU - Arora, Tarun

AU - Brill, Ilene

AU - Kilgore, Meredith L.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The aim of the study is to quantify the impact of bone metastasis and skeletal-related events (SREs) on mortality in older breast cancer patients. Using the linked Surveillance, Epidemiology and End Results-Medicare database, we identified women aged 65 years or older diagnosed with breast cancer between July 1, 1999 and December 31, 2005 and followed them to determine deaths occurring through December 31, 2006. We classified patients as having possible bone metastasis and SREs using discharge diagnoses from inpatient claims and diagnoses paired with procedure codes from outpatient claims. We used Cox regression to estimate mortality hazards ratios (HR) among women with bone metastasis with or without SRE, compared with women without bone metastasis. Among 98,260 women with breast cancer (median follow-up, 3.3 years), 7,189 (7.3%) had bone metastasis either at breast cancer diagnosis (1.5%) or during follow-up (5.8%). SREs occurred in 3,319 (46%) of women with bone metastasis. HRs for risk of death were 4.9 (95% CI 4.7-5.1) and 6.2 (95% CI 5.9-6.5), respectively, for women with bone metastasis but no SRE and for women with bone metastasis plus SRE, compared with women without bone metastasis. In analyses restricted to women with bone metastasis, the adjusted HR was 1.5 (95% CI 1.4-1.6) for women with bone metastasis plus SRE, compared with women with bone metastasis but without SRE. Having a bone metastasis, as indicated by Medicare claims, was associated strongly with mortality among women with breast cancer. This association was stronger for bone metastasis complicated by SRE than for bone metastasis without SRE.

AB - The aim of the study is to quantify the impact of bone metastasis and skeletal-related events (SREs) on mortality in older breast cancer patients. Using the linked Surveillance, Epidemiology and End Results-Medicare database, we identified women aged 65 years or older diagnosed with breast cancer between July 1, 1999 and December 31, 2005 and followed them to determine deaths occurring through December 31, 2006. We classified patients as having possible bone metastasis and SREs using discharge diagnoses from inpatient claims and diagnoses paired with procedure codes from outpatient claims. We used Cox regression to estimate mortality hazards ratios (HR) among women with bone metastasis with or without SRE, compared with women without bone metastasis. Among 98,260 women with breast cancer (median follow-up, 3.3 years), 7,189 (7.3%) had bone metastasis either at breast cancer diagnosis (1.5%) or during follow-up (5.8%). SREs occurred in 3,319 (46%) of women with bone metastasis. HRs for risk of death were 4.9 (95% CI 4.7-5.1) and 6.2 (95% CI 5.9-6.5), respectively, for women with bone metastasis but no SRE and for women with bone metastasis plus SRE, compared with women without bone metastasis. In analyses restricted to women with bone metastasis, the adjusted HR was 1.5 (95% CI 1.4-1.6) for women with bone metastasis plus SRE, compared with women with bone metastasis but without SRE. Having a bone metastasis, as indicated by Medicare claims, was associated strongly with mortality among women with breast cancer. This association was stronger for bone metastasis complicated by SRE than for bone metastasis without SRE.

KW - Bone metastasis

KW - Breast cancer

KW - Medicare beneficiaries

KW - Skeletal-related events

UR - http://www.scopus.com/inward/record.url?scp=84856234931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856234931&partnerID=8YFLogxK

U2 - 10.1007/s10549-011-1721-x

DO - 10.1007/s10549-011-1721-x

M3 - Article

VL - 131

SP - 231

EP - 238

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -